ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF FLAVOXATE HCL WITH RP-HPLC

Authors

  • AAKRITI BHARDWAJ Sanskar College of Pharmacy and Research, Ghaziabad-201001, Uttar Pradesh, India. Principle Scientific Officer, IPC, Ghaziabad-201001, Uttar Pradesh, India
  • ROBIN KUMAR Principle Scientific Officer, IPC, Ghaziabad-201001, Uttar Pradesh, India
  • SHABNAM AIN Sanskar College of Pharmacy and Research, Ghaziabad-201001, Uttar Pradesh, India
  • BABITA KUMAR Sanskar College of Pharmacy and Research, Ghaziabad-201001, Uttar Pradesh, India
  • QURRATUL AIN Sanskar College of Pharmacy and Research, Ghaziabad-201001, Uttar Pradesh, India

DOI:

https://doi.org/10.22159/ijpps.2025v17i4.53045

Keywords:

Accuracy, Flavoxate HCl, HPLC, Precision, Validation

Abstract

Objective: To verify analytical methods, suitability for its intended use is the goal of validation by Reverse Phase-High Performance Liquid Chromatography (RP-HPLC) method.

Methods: A validated method for determining flavoxate hydrochloride was created using HPLC, which is a sensitive, exact, and straightforward technique. The inertsilC18 (150 mm×4.6 mm, 5µm) is used in this approach. The buffer, which included 3g of 1-hexane sulphonic acid, 3 ml of Orthophosphoric Acid (OPA) and 3 ml of Triethylamine (TMA), was combined with Acetonitrile (ACN) in a 650:350 ratio to form the mobile phase. At 293 nm, Ultraviolet (UV) detection was done.

Results: The Retaining time for flavoxate HCl was found to be 2.43 min. It was discovered that the linearity range of flavoxate HCl was 800-1200 µg/ml, and that the regression equation was y=17118x+80943. R 2 = 0.981 was found to be the linearity regression coefficient value. It was discovered that the RSD for intra-and inter-day precision was less than 2 %. Flavoxate HCl was discovered to have Limit of Detection (LOD)-83.13734 and Limit of Quantitation (LOQ)-251.9313 values of µg/ml and µg/ml, respectively. After statistical analysis, the results are deemed satisfactory.

Conclusion: This technique can be used to analyze bulk forms of the antimuscarinic medication flavoxate HCl with success.

Downloads

Download data is not yet available.

References

Yadav AV, Gaud RS. Pharmaceutics. 10th ed. Pragati Books Pvt. Ltd; 2016. p. 1.

Sharma S, Goyal S, Chauhan K. Analytical method development and validation. Int J App Pharm. 2018;10(6):8-15. doi: 10.22159/ijap.2018v10i6.28279.

Ain S, Ain Q, Kumar B. Investigations on novel bio-binder isolated from Aegle marmelos used in ibuprofen tablets. Int J Pharm Pharm Sci. 2015;7(7):414-5.

Henderson E, Drake M. Overactive bladder. Maturitas. 2010 Jul;66(3):257-62. doi: 10.1016/j.maturitas.2010.03.010, PMID 20399043.

Wallace KM, Drake MJ. Overactive bladder. F1000Research. 2015;4:F1000 Faculty Rev-1406. doi: 10.12688/ f1000research.7131.1, PMID 26918151.

Ain S, Philip B, Pathak K. Preformulative assessment of preformed complexes of gemfibrozil, with cyclodextrins. PDA J Pharm Sci Technol. 2008;62(4):300-8. PMID 19174958.

Ain S, Kumar B, Pathak K. Development and characterization of controlled release famotidine matrix tablets containing complexes. Int J Appl Pharm. 2017;9(4):8-46. doi: 10.22159/ijap.2017v9i4.18859.

Sweeney P, Mutambirwa S, Van An N, Sharma JB, Vanamail P. Flavoxate in the symptomatic treatment of overactive bladder: a meta-analysis. Eur Rev Med Pharmacol Sci. 2016;20(17); Sep:3703-12. PMID 27649675.

Fehrmann-Zumpe P, Karbe K, Blessman G. Using flavoxate as primary medication for patients suffering from urge symptomatology. Int Urogynecol J Pelvic Floor Dysfunct. 1999 Apr;10(2):91-5. doi: 10.1007/pl00004018, PMID 10384969.

Bhardwaj SK, Dwivedia K, Agarwala DD. HPLC method development and validation. Int J Anal Bioanal Chem. 2015; Nov;5(4):76-81.

El-Shaheny RN, El-Enany NM, Belal FF. A green HPLC method for the analysis and stability study of flavoxate HCl using micellar eluent. Anal Methods. 2014;6(4):1001-10. doi: 10.1039/C3AY41318G.

Snyder LR, Glajch JL, Kirkland JJ, Abbott RW. Practical HPLC method development. Analytica Chimica Acta. 1991;245:287-8. doi: 10.1016/S0003-2670(00)80235-4.

Guideline, ICH harmonised tripartite. Validation Anal Proc Text Methodol. 2005;Q2(R1):1.20.

Jadhav S, Bhoir G, Jain V. Method development and validation of rapid isocratic RP-HPLC method for simultaneous estimation of paracetamol, caffeine, and propyphenazone in pharmaceutical formulation. Asian J Pharm Clin Res. 2024;17(4):83-7. doi: 10.22159/ajpcr.2024.v17i4.49544.

Guideline, IHT. Stability testing of new drug substances and products, Q1A(R2). Current Step. 2003;4:1-24.

Ain S, Gupta V, KB, Ain Q, Dahiya J. Solubility enhancement of the poorly water-soluble antiulcer drug famotidine by inclusion complexation. PCI- Approved-IJPSN. 2013;6(1):1983-9. doi: 10.37285/ijpsn.2013.6.1.10.

Kumar V, Ain S, Kumar B, Ain Q, Gaurav. Optimization and evaluation of topical gel containing solid lipid nanoparticles loaded with luliconazole and its antifungal activity. Int J Pharm Res. 2020;12(2):2901-12.

Dhama PK, Ain S, Kumar B, Ain Q. Development and evaluation of topical ointment formulation containing gallic acid as an active pharmaceutical ingredient against bacterial infection and oxidative damage. AP. 2022;11(1):439-49. doi: 10.54085/ap.2022.11.1.51.

Guideline, ICH harmonised tripartite. Stability testing: photostability testing of new drug substances and products. Vol. Q1B. Geneva: ICH; 1996. p. 172.

ICH. Stability testing of new drug substances and products. International Conference on Harmonization; Geneva Q1A (R2); 2003.

Stuart BH. Infrared spectroscopy: fundamentals and applications. John Wiley & Sons; 2004. doi: 10.1002/0470011149.

Domon B, Aebersold R. Mass spectrometry and protein analysis. Science. 2006;312(5771):212-7. doi: 10.1126/science.1124619, PMID 16614208.

Rule GS, Kevin Hitchens T. NMR spectroscopy. Springer Netherlands; 2006.

Parveen N, Routh T, Goswami AK, Mondal SA. New robust analytical method development, validation, and stress degradation studies for estimating ritonavir by UV-spectroscopy and HPLC methods. Int J App Pharm. 2023;15(4):214-24. doi: 10.22159/ijap.2023v15i4.47924.

Ali Z, Ain S, Kumar B, Ain Q. Method development and validation for estimation of cefadroxil in different marketed tablets by UV spectrophotometry method and anti-inflammatory studies using in-silico approaches. Orient J Chem. 2022;38(4):898-905. doi: 10.13005/ojc/380409.

Published

01-04-2025

How to Cite

BHARDWAJ, AAKRITI, et al. “ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF FLAVOXATE HCL WITH RP-HPLC”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 17, no. 4, Apr. 2025, pp. 1-11, doi:10.22159/ijpps.2025v17i4.53045.

Issue

Section

Original Article(s)